Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis.

Authors:
Hilscher M; Røder A; Helgstrand JT; Klemann N; Brasso K and 2 more

Journal:
Cancer

Publication Year: 2022

DOI:
10.1002/cncr.34407

PMCID:
PMC9804454

PMID:
35975979

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cancer

Abbreviation: Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Tobacco use and cancer-related symptom burden: Analysis of the US Population Assessment of Tobacco …
Price SN; Palmer AM; Fucito LM and 4 more (2023) - Transparency Score: 3/6
A contemporary systematic review on liver transplantation for unresectable liver metastases of colo…
Lebeck Lee CM; Ziogas IA; Agarwal R and 5 more (2022) - Transparency Score: 3/6
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute mye…
Loke J; Labopin M; Craddock C and 16 more (2022) - Transparency Score: 3/6
Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative hea…
Ekanayake Weeramange C; Shu D; Tang KD and 10 more (2022) - Transparency Score: 3/6
A proposed global framework for pediatric cancer communication research.
Graetz DE; Caceres-Serrano A; Radhakrishnan V and 3 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Andreas Røder reports acting as a consultant for Astellas Pharma, AstraZeneca, Bayer, Merck, Janssen Biotech, and Pfizer Pharma. Andrew Julian Vickers is named on a patent for a statistical method to detect prostate cancer that has been licensed to and commercialized by OPKO Health as the 4Kscore; he receives royalties from sales of the test and has stock options in OPKO Health. Hein Vincent Stroomberg reports support for attending meetings or other travel from Merck. The other author made no disclosures."

Evidence found in paper:

"FUNDING INFORMATION National Cancer Institute, Grant/Award Numbers: P30 CA008748 and P50 CA92629; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025